End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 CNY | +2.05% | +3.17% | -18.32% |
Apr. 25 | Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 07 | Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm | MT |
Sales 2022 | 655M 90.77M | Sales 2023 | 672M 93.07M | Capitalization | 3.39B 470M |
---|---|---|---|---|---|
Net income 2022 | 162M 22.45M | Net income 2023 | 163M 22.59M | EV / Sales 2022 | 5.32 x |
Net Debt 2022 | 213M 29.56M | Net Debt 2023 | 150M 20.75M | EV / Sales 2023 | 5.28 x |
P/E ratio 2022 |
20.3
x | P/E ratio 2023 |
20.7
x | Employees | 746 |
Yield 2022 |
1.79% | Yield 2023 |
-
| Free-Float | 61.24% |
1 day | +2.05% | ||
1 week | +3.17% | ||
Current month | +2.05% | ||
1 month | +3.55% | ||
3 months | +30.31% | ||
6 months | -22.51% | ||
Current year | -18.32% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Jian Zhao
CEO | Chief Executive Officer | 47 | 18-04-22 |
Sun Zhan Lü
DFI | Director of Finance/CFO | 45 | 16-03-11 |
Shi Sheng Li
BRD | Director/Board Member | 73 | 16-03-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tao Jin
BRD | Director/Board Member | 56 | 19-05-05 |
Yi Yi Yan
CHM | Chairman | 75 | 16-03-11 |
Bing Jun Ren
BRD | Director/Board Member | 58 | 16-03-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 8.47 | +2.05% | 5,207,847 |
24-04-30 | 8.3 | +1.10% | 4,691,196 |
End-of-day quote Shanghai S.E., May 05, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-18.32% | 385M | |
+31.80% | 690B | |
+26.04% | 546B | |
-4.62% | 358B | |
+17.62% | 323B | |
+5.57% | 287B | |
+14.42% | 235B | |
+5.60% | 199B | |
-9.57% | 195B | |
+4.53% | 161B |
- Stock Market
- Equities
- 603811 Stock